NFAT1 Is Highly Expressed in, and Regulates the Invasion of, Glioblastoma Multiforme Cells

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Tie, Xinxin ^a   Han, Sheng ^a   Meng, Lingxuan ^a   Wang, Yunjie ^a   Wu, Anhua ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; SHORT HAIRPIN RNA; TACROLIMUS; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFAT1; UNCLASSIFIED DRUG; CYCLOOXYGENASE 2; CYCLOSPORIN; GELATINASE B; MATRILYSIN; MMP7 PROTEIN, HUMAN; NFATC2 PROTEIN, HUMAN; PTGS2 PROTEIN, HUMAN; SMALL INTERFERING RNA;

ARTICLE; CANCER CELL; CANCER GRADING; CARCINOGENESIS; CELL NUCLEUS; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; COX 2 GENE; GENE; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MICROARRAY ANALYSIS; MMP 7 GENE; MMP 9 GENE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR INVASION; ANTAGONISTS AND INHIBITORS; BIOPSY; BRAIN TUMOR; CELL CYCLE; DNA MICROARRAY; DRUG EFFECTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

BIOPSY; BRAIN NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; CYCLOOXYGENASE 2; CYCLOSPORINE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; MATRIX METALLOPROTEINASE 7; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; NFATC TRANSCRIPTION FACTORS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, SMALL INTERFERING; TACROLIMUS;

EID: 84878805880     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066008     Document Type: Article

References (37)

1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, et al. (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114: 97-109.
2. Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY, et al. (2010) Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin 60: 166-193.
3. Joseph JV, Balasubramaniyan V, Walenkamp A, Kruyt FA, (2013) TGF-beta as a therapeutic target in high grade gliomas- Promises and challenges. Biochem Pharmacol 85: 478-485.
4. Tsuda M, Tanaka S, (2012) Roles for crk in cancer metastasis and invasion. Genes Cancer 3: 334-340.
5. Ma J, Cui W, He SM, Duan YH, Heng LJ, et al. (2012) Human U87 astrocytoma cell invasion induced by interaction of betaig-h3 with integrin alpha5beta1 involves calpain-2. PLOS ONE 7: e37297.
6. Chen L, Zhang W, Yan W, Han L, Zhang K, et al. (2012) The putative tumor suppressor miR-524-5p directly targets Jagged-1 and Hes-1 in glioma. Carcinogenesis 33: 2276-2282.
7. Qian X, Ren Y, Shi Z, Long L, Pu P, et al. (2012) Sequence-dependent synergistic inhibition of human glioma cell lines by combined temozolomide and miR-21 inhibitor gene therapy. Mol Pharm 9: 2636-2645.
8. Zhang C, Zhang J, Hao J, Shi Z, Wang Y, et al. (2012) High level of miR-221/222 confers increased cell invasion and poor prognosis in glioma. J Transl Med 10: 119.
9. Wu A, Ericson K, Chao W, Low WC, (2010) NFAT and AP1 are essential for the expression of a glioblastoma multiforme related IL-13Ra2 transcript. Cell Oncol 32: 313-329.
10. Crabtree GR, Schreiber SL (2009) SnapShot: Ca2+-calcineurin-NFAT signaling. Cell 138: 210, 210.e1.
11. Vazquez-Cedeira M, Lazo PA, (2012) Human VRK2 (vaccinia-related kinase 2) modulates tumor cell invasion by hyperactivation of NFAT1 and expression of cyclooxygenase-2. J Biol Chem 287: 42739-42750.
12. Amir M, Romano S, Goldman S, Shalev E, (2009) Plexin-B1, glycodelin and MMP7 expression in the human fallopian tube and in the endometrium. Reprod Biol Endocrinol 7: 152.
13. Lee YS, Lan THT, Van Ta Q, (2009) Regulation of expression of matrix metalloproteinase-9 by JNK in Raw 264.7 cells: presence of inhibitory factor(s) suppressing MMP-9 induction in serum and conditioned media. Exp Mol Med 41: 259-268.
14. Muller MR, Rao A, (2010) NFAT, immunity and cancer: a transcription factor comes of age. Nat Rev Immunol 10: 645-656.
15. Yiu GK, Toker A, (2006) NFAT induces breast cancer cell invasion by promoting the induction of cyclooxygenase-2. J Biol Chem 281: 12210-12217.
16. Jauliac S, Lopez-Rodriguez C, Shaw LM, Brown LF, Rao A, et al. (2002) The role of NFAT transcription factors in integrin-mediated carcinoma invasion. Nat Cell Biol 4: 540-544.
17. Jacobs VL, Landry RP, Liu Y, Romero-Sandoval EA, De Leo JA, (2012) Propentofylline decreases tumor growth in a rodent model of glioblastoma multiforme by a direct mechanism on microglia. Neuro Oncol 14: 119-131.
18. Schnell O, Romagna A, Jaehnert I, Albrecht V, Eigenbrod S, et al. (2012) Kruppel-like factor 8 (KLF8) is expressed in gliomas of different WHO grades and is essential for tumor cell proliferation. PLOS ONE 7: e30429.
19. Najbauer J, Huszthy PC, Barish ME, Garcia E, Metz MZ, et al. (2012) Cellular host responses to gliomas. PLOS ONE 7: e35150.
20. Jacobs VL, Liu Y, De Leo JA, (2012) Propentofylline targets TROY, a novel microglial signaling pathway. PLOS ONE 7: e37955.
21. Dikshit B, Irshad K, Madan E, Aggarwal N, Sarkar C, et al. (2012) FAT1 acts as an upstream regulator of oncogenic and inflammatory pathways, via PDCD4, in glioma cells.LID- 10.1038/onc.2012.393 [doi]. Oncogene.
22. Oh MC, Kim JM, Safaee M, Kaur G, Sun MZ, et al. (2012) Overexpression of calcium-permeable glutamate receptors in glioblastoma derived brain tumor initiating cells. PLOS ONE 7: e47846.
23. Soroceanu L, Murase R, Limbad C, Singer EL, Allison J, et al. (2012) Id-1 is a Key Transcriptional Regulator of Glioblastoma Aggressiveness and a Novel Therapeutic Target. Cancer Res.
24. Kim KH, Seol HJ, Kim EH, Rheey J, Jin HJ, et al. (2013) Wnt/beta-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells. Neuro Oncol 15: 161-171.
25. Stechishin OD, Luchman HA, Ruan Y, Blough MD, Nguyen SA, et al. (2013) On-target JAK2/STAT3 inhibition slows disease progression in orthotopic xenografts of human glioblastoma brain tumor stem cells. Neuro Oncol 15: 198-207.
26. De Rosa A, Pellegatta S, Rossi M, Tunici P, Magnoni L, et al. (2012) A Radial Glia Gene Marker, Fatty Acid Binding Protein 7 (FABP7), Is Involved in Proliferation and Invasion of Glioblastoma Cells. PLOS ONE 7: e52113.
27. Rath BH, Fair JM, Jamal M, Camphausen K, Tofilon PJ, (2013) Astrocytes enhance the invasion potential of glioblastoma stem-like cells. PLOS ONE 8: e54752.
28. Flockhart RJ, Diffey BL, Farr PM, Lloyd J, Reynolds NJ, (2008) NFAT regulates induction of COX-2 and apoptosis of keratinocytes in response to ultraviolet radiation exposure. FASEB J 22: 4218-4227.
29. Iniguez MA, Martinez-Martinez S, Punzon C, Redondo JM, Fresno M, (2000) An essential role of the nuclear factor of activated T cells in the regulation of the expression of the cyclooxygenase-2 gene in human T lymphocytes. J Biol Chem 275: 23627-23635.
30. Duque J, Fresno M, Iniguez MA, (2005) Expression and function of the nuclear factor of activated T cells in colon carcinoma cells: involvement in the regulation of cyclooxygenase-2. J Biol Chem 280: 8686-8693.
31. John A, Tuszynski G, (2001) The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol Oncol Res 7: 14-23.
32. Zheng J, Fang F, Zeng X, Medler TR, Fiorillo AA, et al. (2011) Negative cross talk between NFAT1 and Stat5 signaling in breast cancer. Mol Endocrinol 25: 2054-2064.
33. Robbs BK, Cruz AL, Werneck MB, Mognol GP, Viola JP, (2008) Dual roles for NFAT transcription factor genes as oncogenes and tumor suppressors. Mol Cell Biol 28: 7168-7181.
34. Faget DV, Lucena PI, Robbs BK, Viola JP, (2012) NFAT1 C-terminal domains are necessary but not sufficient for inducing cell death. PLOS ONE 7: e47868.
35. Liao Q, Li Z, Chen R, Guo N, Zeng B, et al. (2012) [Effect of hepatitis C virus core gene transfection on NFAT1 expression in human intrahepatic cholangiocarcinoma cells]. Nan Fang Yi Ke Da Xue Xue Bao 32: 789-793.
36. Rafferty P, Egenolf D, Brosnan K, Makropoulos D, Jordan J, et al. (2012) Immunotoxicologic effects of cyclosporine on tumor progression in models of squamous cell carcinoma and B-cell lymphoma in C3H mice. J Immunotoxicol 9: 43-55.
37. Muellenhoff MW, Koo JY, (2012) Cyclosporine and skin cancer: an international dermatologic perspective over 25 years of experience. A comprehensive review and pursuit to define safe use of cyclosporine in dermatology. J Dermatolog Treat 23: 290-304.